BIO-Europe® 2016: Welcome and Opening Plenary Discussion

October 28, 2016
Balancing the cost of innovation and ensuring access to high-quality, effective medical treatment continues to be a challenge for all modern healthcare systems. Significant shifts in global and local market dynamics, policy and politics are prompting a discussion about other dimensions of value, be they economic, social, or scientific. How can biotech innovators best demonstrate the value of their therapies so that outcomes are measurable and relevant to all stakeholders?
Previous Video
BIO-Europe® 2016- Value and the pricing of innovation
BIO-Europe® 2016- Value and the pricing of innovation

Balancing the cost of innovation and ensuring access to high-quality, effective medical treatment continues...

Next Video
Livestream von EBDGROUPChannel
Livestream von EBDGROUPChannel